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ABSTRACT 
The manifestation of multidrug resistance in bacteria over the past several decades has 
resulted in one of the foremost challenges in the management of infectious diseases. The 
question arises, “How do we address this growing problem?” One solution to stem the 
growing rise in antimicrobial resistance is to investigate new targets, while another approach 
is to re-examine classical antibacterial targets with a fresh perspective. The aim of this paper 
is to begin the process of antibacterial development for the pathogen Clostridium difficile by 
characterizing the cell wall acting glucosaminidase CD1034. It is inunderstanding how 
CD1034 functions biochemically that it can be targeted for antibacterial development. The 
gene CD1034 was successfully cloned and sequenced in this project. Results have 
implications in the further development of an antibiotic for C. difficile and other Gram-
positive pathogens.
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INTRODUCTION 
Hospitals today are ridden with disease, whether it is from the patients entering to be 
treated or the dormant bacteria loitering within. Nosocomial infections are defined by the 
World Health Organization (WHO) as infections acquired by a patient who was admitted for 
reasons other than that infection (World Health Organization Department of Communicable 
Disease, Surveillance and Response, 2002). These infections are prevalent world-wide, from 
hospitals in developing nations to countries such as the United States. In this study by WHO, 
it was found that nosocomial infections were most common at the sites of surgical wounds, in 
the urinary tract, and in the lower respiratory tract. Nosocomial infections are one of the 
leading causes of death in hospitals, and can also lead to a reduction in the quality of life of 
patients due to excess stress and emotions from the infection. Many of these bacterial 
infections are becoming larger problems due to the bacteria’s resistance to antibiotics.  
Antibiotic resistance in a particular bacterium can happen in a few different ways. If 
the bacterium is constantly being exposed to a specific type of antibiotic treatment, there are 
ways in which it is able to adapt to not be affected by that treatment. This can happen in one 
of two ways. The first is through the mutation of chromosomes, which is extremely rare. The 
second method, which is far more common, is through a method called transmissible drug 
resistance, or TRD for short (Black's Veterinary Dictionary, 2005). This is a method where 
bacteria that carry what are known as R factors (resistance factors) in their cytoplasm are able 
to pass the R factors on to other bacteria via contact. The R factors are transferred through 
amedium called plasmids. This most commonly happens between bacteria that occupy the 
intestinal tracts of humans, and usually occurs when the person who is hosting the bacteria is 
receiving antibiotics for another infection. When that patient receives antibiotics, it disrupts 
the normal colonic flora and makes the conditions perfect for the R factor transfer. This can 
cause a patient who is already infected to become infected with a new bacterium, one which is 
antibiotic resistant.  
One particular type of bacteria that is becoming particularly troublesome in hospitals 
is Clostridium difficile (C. difficile). C. difficileis a gram-positive organism, which means that 
the cell wall is made of a thick layer of peptidoglycans. This bacterium currently has no easy 
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and effective treatment, and has not responded to any type of antibiotics thus far. C. difficile is 
a fecal organism that is rampant in hospitals and the major cause of hospital acquired cases of 
diarrhea (Youngson, 2005). C. difficile targets those patients in a hospital that are at the 
highest risk for nosocomial infections. These are the elderly patients, those who are 
immunocompromised, and those who are on antibiotic regiments. Those who are on 
antibiotics are at risk because the antibiotics disrupt the normal bacteria of the bowel, 
allowing the bacterium to become well-established in the colon and intestines (Webster's New 
World Medical Dictionary). Those who are elderly and immunocompromised are at risk of 
non-normal flora, which, as previously stated, is the height of when C. difficilewill establish 
itself in the body. It is also a tough bacterial infection to fight because some patients show 
symptoms of infection rather quickly, while others do not show them whatsoever and become 
what is known as a “carrier.” These carriers are dangerous because C. difficile is a spore-
producing bacterium and can quickly and easily spread from the carriers to the new victims. 
The ability of the bacterium to produce spores, create carriers within the hospital 
environment, and infect and re-infect those patients at the highest risk are the main reasons 
why the spread of C. difficilehas significantly increased over the past decade (Wheeldon, 
Worthington, Hilton, Elliott, & Lambert, 2008). Figure 1 reveals infection rates for those 
patients aged 65 and older since only 1996, as shown in a study by the Centers for Disease 
Control and Prevention.  
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Figure 1 – Infection Rates of C. difficile in US Hospitals from 1996 – 2009 
The figure shows increases in infection rates of 175% for those aged 65 – 74 years old, 198% 
for those aged 75 – 84, and 201% for those aged ≥85 years of age. A total infection rate 
increase of 200% for all patients aged ≥65 was found in this study as well. This is an 
enormous increase from 1996 alone, never mind from decades prior. This study by the CDC 
confirms prior studies that the elderly are at a higher risk of infection as well(Centers for 
Disease Control and Prevention, 2011). 
C. difficile is not only a major problem for patients in the hospital, but also to the 
hospital itself.Hospitals are at risk of becoming subject to extremely high treatment costs 
when looking into infections caused by C. difficile. Average daily costs for treating infections 
causes by C. difficile ranges from 17.6 – 51.5 million dollars (Stabler, 2009). The range of 
costs for first-time infected patients is $2,871 - $4,846 per case and $13,655 - $18,067 per 
case for those patients who are re-infected (Ghantoji, Sail, Lairson, DuPont, & Garey, 2010). 
This leads to costs in excess of $1 billion in the US annually. These numbers are staggering, 
and are far too high for hospitals struggling to control costs. The need for an antimicrobial 
now is extremely high. According to Herbert Dupont, other researchers are in the field 
looking to develop a way to inhibit the infection process, much like this project intends to do. 
However, some of those projects are looking to develop a way to restore or preserve the 
colonic flora while taking antibiotics (Dupont, 2011). This approach is new and innovative, 
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much like the approach this project takes on to inhibit the cell wall adhesion process of C. 
difficile to the intestine wall. 
 This project will focus on the beginning stages of antimicrobial development for C. 
difficile, more specifically the cloning and characterization of the cell wall acting enzyme 
CD1034. CD1034 is a glucosaminidase specific to C. difficile, however has homologs in other 
Gram-positive pathogens, which will lead to outside applications of the results. A 
glucosaminidase is an enzyme which has the ability to hydrolyze peptidoglycans, which 
means that CD1034 cleaves the glycosidic bond via the addition of water. This is very 
important due to the fact that C. difficileis gram-positive with that thick layer of 
peptidoglycans in its cell wall. From this, it is hypothesized that CD1034 is annotated in the in 
the C. difficile genome to act on bacterial peptidoglycan as a β-glucosaminidase with the 
ability to cleave peptidoglycans. Overall, this project seeks to begin the discovery process of 
potential proteins that will be able to be developed further into methods of preventing or 
stopping the infection process of C. difficile. The lab work, data collected, and further analysis 
and conclusions that will be developed over the course of this Senior Capstone will help all 
further researchers in taking this project a step further into developing an antimicrobial 
against C. difficile. 
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METHODS AND MATERIALS 
Getting to Know the Lab 
The first week of work for this Capstone began with learning more about the equipment I 
would be using daily throughout the course of the experimentation. A sample of the 
equipment I learned about this beginning week is: 
1. Pipets (used to measure out small amounts of chemicals for solutions and can be easily 
misued), 
2. Autoclave (used to sterilize equipment such as flasks in a high pressure/high heat 
environment for use in experimentation), 
3. Polymerase chain reaction machine, and 
4. Gel electrophoresis (used to run the polymerase chain reaction solutions in to check 
for success in the reaction against a base). 
This first week of learning about the equipment to be used was crucial for the success of the 
remainder of the project. 
PCRof CD1034 with AccuTaq Polymerase 
A 50x TAE buffer was first made for the gel electrophoresis stage of this step. This buffer 
was a solution of Trizma base, glacial acetic acid, EDTA, and deionized water. With this 
buffer made, the first of three polymerase chain reactions (PCR) was set up. The purpose of 
this reaction is to amplify the CD1034 gene, the cell wall acting enzyme that is strongly 
thought to be involved in Clostridium difficilegrowth and division. The reagents of the 
reaction included genomic DNA Cd630, which is the DNA of C. difficile that contains the 
gene CD1034. The Sigma AccuTaq PCR Kit was used for this reaction, which utilizes taq 
polymerase. Taq polymerase is one of the more cost-effective and commonly used 
polymerases on the market. The DNA primer AV-1 was used as the forward primer and has 
the sequence:  
5’ – AAGACCCCATATGGCTAGAAAATTAATAAAAAATTTGGG – 3’ 
This forward primer is specifically engineered with an NdeI restriction site for cloning into 
the plasmid pET28. The reverse primer AV-3 was used with the sequence: 
5’ – TCTCGAGTTATTTTGTCTCAACTTTATTATCTATC – 3’ 
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This reverse primer was also engineered specifically with an XhoI restriction site for cloning 
into the plasmid pET28. The conditions of the first PCR can be found in Table 1. 
Table 1 – Conditions of the PCR of CD1034 with AccuTaq Polymerase 
 
Denaturing Extension Sit Stage
98º C 94º C 55º C 68º C 68º C 4º C
48 sec. 20 sec. 20 sec. 1 min. 10 min. Infinite
Annealing
The reaction was analyzed in a 1% agarose gel electrophoresis, which is a scientific technique 
that separates a population of DNA by size. This step is crucial in determining if the PCR was 
successful in replicating the CD1034 portion of the genomic DNA. A GeneRuler 1 kb ladder 
was placed into the first lane of the gel and the reaction was placed into the second lane of the 
gel. The GeneRuler ladder is run against the reaction because the section of the DNA that is 
expected to show on the gel (it will be a thick stain if the DNA was replicated because the 
DNA is separated by size and amount) is approximately 1000 bases from the start of the 
strand. 
Effect of MgCl2on PCR of CD1034 withAccuTaq Polymerase  
A second PCR was performed to amplify CD1034. The same genomic DNA, PCR kit, and 
forward and reverse primers were used as from the first PCR, however additional magnesium 
chloride (MgCl2) was added in different levels to this reaction. The first reaction contained an 
additional 0.5 µL (microliters) of MgCl2. The second reaction contained an additional 1 µL of 
MgCl2. The third reaction contained an additional 1.5 µL of MgCl2. Finally, the fourth 
reaction contained an additional 2 µL of MgCl2. These four concentrations of MgCl2 were 
added to try to find the ideal conditions in which the PCR would run. The conditions of the 
PCR can be seen in Table 2. The gel was run on these four PCR products, with the GeneRuler 
in the first lane, the four different reactions mentioned above in lanes 2-5 (respectively) and 
the genomic DNA in lane 6. 
Table 2 –Conditions of the PCR of CD1034 with AccuTaq Polymerase & Addition of MgCl2 
 
Denaturing Extension Sit Stage
98º C 94º C 50º C 68º C 68º C 4º C
48 sec. 20 sec. 20 sec. 1 min. 10 min. Infinite
Annealing
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PCR of CD1034 with 5 Prime PCR Extender System 
The third attempt at amplifying CD1034 was taken in a different direction. The 5 Prime PCR 
Extender System was used in place of the Sigma AccuTaq PCR Kit, in addition to the same 
genomic DNA and primers as stated in previous reactions. The 5 Prime PCR Extender System 
includes a polymerase that is a blend of thermostable DNA polymerases with a processivity-
enhancing factor that provides a high extension rate and maximal proofreading capability and 
also two different types of buffer – tuning buffer and high fidelity buffer. Four reactions were 
developed for this PCR, two reactions with tuning buffer and two reactions with high fidelity 
buffer. The two reactions for each buffer included different levels of genomic DNA Cd630 as 
to find the optimal level. The conditions of the PCR can be seen in Table 3. The gel was run 
with the following lanes: 
1. GeneRuler 1 kb ladder 
2. Tuning Buffer with Mg with 1.25 µL of genomic DNA CD630 
3. Tuning Buffer with Mg with 2.5 µL of genomic DNA CD630 
4. High Fidelity Buffer with Mg with 1.25 µL of genomic DNA CD630 
5. High Fidelity Buffer with Mg with 2.5 µL of genomic DNA CD630. 
Table 3 – Conditions of the PCR using the 5 Prime PCR Extender System 
 
Denaturing Extension Sit Stage
93º C 93º C 55º C 68º C 68º C 12º C
2 min. 30 sec. 45 sec. 1 min. 10 min. Infinite
Annealing
Clean-up of PCR Reactions 
The successful polymerase chain reaction solution must be cleaned up before any further 
experimentation can take place. A cleanup of this reaction was performed using a Sigma 
GenElute PCR Cleanup Kit. This cleanup was performed to rid the solution of any excess 
nucleotides that were not used in the reaction, excess primers, and other excess material from 
the PCR. The manufacturer’s instructions were followed to clean up the successful PCR 
solution. First, DNA is bound on a silica membrane within the spin column. The DNA bound 
to the column is washed and the clean DNA is eluted in buffer. This purifies and recovers 
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approximately 95% of PCR product and more than 99% of primers and primer-dimers are 
removed, leaving product ready for further experimentation. 
Isolation of Plasmids 
pET28 is the plasmid that is to be used for the purposes of this project. This particular plasmid 
was propagated from Escherichia coli DH5α competent cells. The plasmids were prepared 
using a Sigma GenElute Plasmid MiniPrep Kit. The manufacturer’s instructions were 
followed to prepare the plasmids. The cells were first harvested from recombinant E. coli. 
Next, the cultured cells were re-suspended in a re-suspension solution and from here they 
were lysed by the addition of a Lysis Solution. The solution was mixed by means of gentle 
inversion as to prevent the shearing of genomic DNA. The cells are then neutralized and 
gently inverted again, and this solution is then transferred to a binding column. The elution is 
performed, and thus the DNA is now present in the eluate and ready for experimentation. 
RestrictionDigest of CD1034 & pET28 
CD1034 and pET28 were digested after being cleaned and prepared. The purpose of the 
digestion process is to ensure that all DNA fragments that have been replicated are the same 
size. The reagents for the digestion included 10 µL of nuclease-free H2O, 2 µL of 10x buffer, 
6 µL of the successful PCR product, 6 µL of the vector (pET28 plasmid), and also 0.5 µL of 
both NdeI and XhoI. The product of the restriction digest was placed on the hot block for 
approximately one hour, and after that hour an addition 0.5 µL of both NdeI and XhoI were 
added to the solution. 
Ligation of CD1034 into pET28 
The first ligation was begun with a double restriction site cut of the vector. The reagents in the 
ligation included 2 µL of 10x buffer for T4 DNA ligase with 10 mM ATP, 10 µL of PCR 
insert, 5 µL of vector, 1 µL of ligase, and 2 µL of sterilized H2O. The resulting solution was 
plated and left to grow overnight in the incubator.  
The second ligation was begun with individual cuts of both the promoter and terminator ends 
of the vector, which would increase the accuracy of the cut to nearly 100%. Two trials with 
individual cuts were made, and the reagents for these ligations can be seen in Table 4. Both 
ligation products were plated and left to grow overnight in an incubator. 
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Table 4 – Reaction Conditions for Ligations with Individual Restriction Site Cuts 
 10 ng Vector:60 ng Insert 10 ng Vector:120 ng Insert 
Vector 0.8 µL 0.8 µL 
Insert 1 µL 2 µL 
10x Buffer 1 µL 1 µL 
Ligase 0.5 µL 0.5 µL 
H2O 6.7 µL 5.7 µL 
Total Volume 10 µL 10 µL 
Sequencing of Successful Ligation 
The colonies of the successful ligation were sent to the Rhode Island Genomics and 
Sequencing Center to be sequenced. The sequencing results were promptly sent back to 
Bryant Labs to be further analyzed and discussed. 
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RESULTS 
Different attempts to amplify the gene CD1034 were made in the beginning stages of this 
project. After three attempts, the polymerase chain reaction to amplify CD1034 was best 
when using the 5 Prime PCR Extender Kit. The specific reaction using this kit that was 
successful had the addition of the Tuning Buffer with magnesium to 1.25 microliters of 
genomic DNA. With the addition of the magnesium, this adds a positively charged ion to the 
reaction, thus helping the negatively charged genomic DNA to react differently. The results of 
the first PCR with only AccuTaq polymerase can be seen in Appendix A. Appendix B shows 
the results from the second PCR with the AccuTaq polymerase and addition of MgCl2. 
Finally, Appendix C shows the gel electrophoresis results from the third and final PCR with 
the 5 Prime PCR Extender System. These results show that lane 2 (lane assignments are from 
left to right, starting at lane 1) of the agarose gel electrophoresis (the successful reaction) has 
the stain at approximately the 1000 base pair line on the GeneRuler, thus confirming 
successful amplification of the CD1034 gene from the PCR. The successful PCR reaction was 
the one in which tuning buffer was used in combination with 1.25 25 µL of genomic DNA 
Cd630. 
After a successful polymerase chain reaction was completed, it was then found that ligation 
was only successful when the cutting of the plasmid was performed in two separate steps – 
the forward cut and the reverse cut. The attempts at DNA ligation were unsuccessful when a 
more efficient and less accurate double cut were made, thus the extra step is necessary for 
100% accuracy. A 12:1 ratioof PCR insert to vector was also found to be successful in 
ligation.  
Finally, the sequencing results revealed that the gene CD1034 was successfully transformed 
into the plasmid, pET28. Appendix D shows the forward sequencing results, revealing a 99% 
match of the gene sequenced check against the known sequence of CD1034. The 1% mistake 
is a silent transformation and is irrelevant. Appendix E shows the reverse sequence of the 
gene sequenced check against the known CD1034 sequence. This 99% match is also only off 
by 1% again because of a silent transformation that is irrelevant and does not change the gene 
itself. 
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DISCUSSION 
Understanding the steps of the polymerase chain reaction process are key to seeing why it is 
possible to amplify a particular gene over a billion replications in just over 2 hours’ time. In 
the denaturing stage, the DNA is brought to a high temperature to separate it into single 
strands (in laymen’s terms, unzipping the DNA strand to its forward and reverse sequences). 
After this stage, the annealing stage begins. The beginning of this stage cools the DNA to 
allow for the primers to attach to their specific sites on the individual strands. The final stage, 
extension, is when the polymerase used in the process attaches to the priming sites and 
extends, or synthesizes, the strands into exact replications of the original DNA strands. This 
cycle of three stages is repeated 25-30 times, and this will yield upwards of 1 billion 
replications of the original strand of DNA if successful. The “sit” stage is not timed and is a 
setting in the PCR machine to allow for a reaction to run without human supervision and be 
ready to go when necessary. 
It is also necessary to understand why the magnesium was added to the reactions and why it is 
important in a successful polymerase chain reaction. Magnesium, or some form of it 
(commonly used MgCl2, or magnesium chloride) is necessary as a cofactor to the DNA 
polymerase used in the reaction. It is not consumed in the reaction, but without it the reaction 
will be unsuccessful. The phosphate backbone of DNA has a negative charge to it, and thus 
the positive charge of MgCl2 blocks this negative charge and allows for the DNA polymerase 
to bind to the primers. Without this charge blockage, the polymerase would be unable to bind 
and thus the replication process would fail. 
The type of polymerase was also a major factor in the success of the PCR. It was found that 
the polymerase from the 5 Prime PCR Extender System was successful. This more-expensive 
DNA polymerase is marketed as having an additional component that increases accuracy of 
the reaction and the proofreading capability. The buffers, both tuning and high fidelity, also 
add to the success of the reaction by better maintaining pH balance at high temperatures, thus 
reducing the possibility of DNA degradation at high temperatures. 
One other point of discussion that was discussed in the Methods and Materials section was the 
plasmid used for experimentation. pET28 is the vector used, and it was chosen for a few 
reasons. The first is because of the presence of the Kan resistance factor, which is the 
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antibiotic resistance factor that is necessary for growth when plated. The second reason is 
because of the NdeI forward restriction site and XhoI reverse restriction site. These were 
easily engineered into the forward and reverse primers to allow for easy ligation. Finally, the 
vector has six histidines that are specifically engineered for easier post-transformation clean-
up of the vector. 
Finally, a discussion of how a ligation was deemed unsuccessful is necessary. This was 
determined when no colonies were found on the media plate the next day, thus confirming 
that no vectors were able to survive the conditions (they would have survived and formed 
colonies had the PCR insert successfully ligated into the vector). The ligation process was 
unsuccessfully attempted four trials; however it could not be determined why the ligation was 
not working. Finally, it was determined that instead of performing a less-accurate double cut 
of the vector; both cuts on the vector would be performed separately, thus ensuring 100% 
accuracy. The final reactions where individual restriction site cuts were made finally yielded 
success. 
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1 2
First gel electrophoresis output with lane products as follows: 
1. 1 kb GeneRuler  
2. Product of PCR using AccuTaq Polymerase 
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2 31 4 5 6
The second gel electrophoresis output with lane products as follows: 
1. GeneRuler 1 kb ladder 
2. Product of PCR with additional 0.5 µL of MgCl2 
3. Product of PCR with additional 1 µL of MgCl2 
4. Product of PCR with additional 1.5 µL of MgCl2 
5. Product of PCR with additional 2 µL of MgCl2 
6. Genomic DNA Cd630 
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2 31 4 5
The third gel electrophoresis output with lane products as follows: 
1. GeneRuler 1 kb ladder 
2. Tuning Buffer with Mg with 1.25 µL of genomic DNA CD630 
3. Tuning Buffer with Mg with 2.5 µL of genomic DNA CD630 
4. High Fidelity Buffer with Mg with 1.25 µL of genomic DNA CD630 
5. High Fidelity Buffer with Mg with 2.5 µL of genomic DNA CD630 
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Appendix D – Forward Sequence of Successful Ligation Compared to Known CD1034 
Sequence using Primer Complementary to the T7 Promotor on pET28 
 
Forward Sequence – T7 Promoter Primer
 >lcl|43923  Length=975 
 
 Score = 1504 bits (814),  Expect = 0.0 
 Identities = 816/817 (99%), Gaps = 0/817 (0%) 
 Strand=Plus/Plus 
 
Query  87   ATGGCTAGAAAATTAATAAAAAATTTGGGTAAAAGTAAAAGTGTAAAGAGAGTGAAACTT  146 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  1    ATGGCTAGAAAATTAATAAAAAATTTGGGTAAAAGTAAAAGTGTAAAGAGAGTGAAACTT  60 
 
Query  147  TTATTTAAGAAGATTTTTATTACTGTATTCATAGTAGCAAGTATAGTTGCTATTTTTAAT  206 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  61   TTATTTAAGAAGATTTTTATTACTGTATTCATAGTAGCAAGTATAGTTGCTATTTTTAAT  120 
 
Query  207  ATAACGAAATATTTTGAGGAATTATACAAAGTAAGGGATTTAAAAAGTACTAAAATTGAA  266 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  121  ATAACGAAATATTTTGAGGAATTATACAAAGTAAGGGATTTAAAAAGTACTAAAATTGAA  180 
 
Query  267  TACTATATGGATGTGGCTGATGAAGCAGGAGATGGAAAGGTCCAATTAAGTTGGAAGGCC  326 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  181  TACTATATGGATGTGGCTGATGAAGCAGGAGATGGAAAGGTCCAATTAAGTTGGAAGGCC  240 
 
Query  327  TTACTTGCTATAGACATGGTAATACATGATGAAGATTTAAGTAATATAAAAAAGAAAGAC  386 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  241  TTACTTGCTATAGACATGGTAATACATGATGAAGATTTAAGTAATATAAAAAAGAAAGAC  300 
 
Query  387  ACATTGGATATAGGGGAAAAGTTTATAGTAGAAGATAAAAATGATAAAGGCGAAAAGGTG  446 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  301  ACATTGGATATAGGGGAAAAGTTTATAGTAGAAGATAAAAATGATAAAGGCGAAAAGGTG  360 
 
Query  447  TATAAGGTAAAAAAGTTTAATAAAGTATTAAGCGAATTGAAATTTGACTCTTCTCAAAAA  506 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  361  TATAAGGTAAAAAAGTTTAATAAAGTATTAAGCGAATTGAAATTTGACTCTTCTCAAAAA  420 
 
Query  507  AGTAGAGCAAGAAAATACATGAAAGATTTAGAATACACATACCTTGGAAATAAACAATTA  566 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  421  AGTAGAGCAAGAAAATACATGAAAGATTTAGAATACACATACCTTGGAAATAAACAATTA  480 
 
Query  567  GATAGTAGTGATGAAAAAATTAAATTTATAAAGAAGTTAGAAGACTCAGCTATAAGAGAA  626 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  481  GATAGTAGTGATGAAAAAATTAAATTTATAAAGAAGTTAGAAGACTCAGCTATAAGAGAA  540 
 
Query  627  TATATTGATTATGGAATATTGCCCTCTATAACAATTGGACAAGCTATATTAGAATCTGGT  686 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  541  TATATTGATTATGGAATATTGCCCTCTATAACAATTGGACAAGCTATATTAGAATCTGGT  600 
 
Query  687  TGGGGAAATTCTAAACTTACAAAACAGAGTAATAATTTATTTGGTATAAAAGCAGATAAA  746 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  601  TGGGGAAATTCTAAACTTACAAAACAGAGTAATAATTTATTTGGTATAAAAGCAGATAAA  660 
 
Query  747  GCATGGAAAGGAAAAAGTGTAGAAATTTCAACTTCAGAGCATTATAATGAAAAAATTGTT  806 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||  
Sbjct  661  GCATGGAAAGGAAAAAGTGTAGAAATTTCAACTTCAGAGCATTATAATGAAAAAATTGTA  720 
 
Query  807  GCTAGTTTTAGGTCGTATAATTCATTACAAGATTCTGTCAAAGACCACAGTTTATTTTTA  866 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  721  GCTAGTTTTAGGTCGTATAATTCATTACAAGATTCTGTCAAAGACCACAGTTTATTTTTA  780 
 
Query  867  ATTAATAATAAAAGATATAGAAAACATGGGTTGTTTG  903 
            ||||||||||||||||||||||||||||||||||||| 
Sbjct  781  ATTAATAATAAAAGATATAGAAAACATGGGTTGTTTG  817
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Appendix E –Reverse Sequence of Successful Ligation Compared to Known CD1034 
Sequence using Primer Complementary to the Polymerase Termination Sequence on pET28 
 
Reverse Complement – T7 Terminator Primer
>lcl|56645  
Length=975 
 
 Score = 1676 bits (907),  Expect = 0.0 
 Identities = 913/916 (99%), Gaps = 1/916 (0%) 
 Strand=Plus/Minus 
 
Query  47   TTATTTTGTCTCAACTTTATTATCTATCAATTGCAAATTATAACTCCTAATAACATCTAT  106 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  975  TTATTTTGTCTCAACTTTATTATCTATCAATTGCAAATTATAACTCCTAATAACATCTAT  916 
 
Query  107  TAATAGCTCTGCATATATACGATTTCCTTTTTTATCTTCTGCTGTACTATATCCTGCATT  166 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  915  TAATAGCTCTGCATATATACGATTTCCTTTTTTATCTTCTGCTGTACTATATCCTGCATT  856 
 
Query  167  TTCTAATGCTTGAGCTTGACTAATATAATCTTTTGCCTCAAACAACCCATGTTTTCTATA  226 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  855  TTCTAATGCTTGAGCTTGACTAATATAATCTTTTGCCTCAAACAACCCATGTTTTCTATA  796 
 
Query  227  TCTTTTATTATTAATTAAAAATAAACTGTGGTCTTTGACAGAATCTTGTAATGAATTATA  286 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  795  TCTTTTATTATTAATTAAAAATAAACTGTGGTCTTTGACAGAATCTTGTAATGAATTATA  736 
 
Query  287  CGACCTAAAACTAGCAACAATTTTTTCATTATAATGCTCTGAAGTTGAAATTTCTACACT  346 
            ||||||||||||||| |||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  735  CGACCTAAAACTAGCTACAATTTTTTCATTATAATGCTCTGAAGTTGAAATTTCTACACT  676 
 
Query  347  TTTTCCTTTCCATGCTTTATCTGCTTTTATACCAAATAAATTATTACTCTGTTTTGTAAG  406 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  675  TTTTCCTTTCCATGCTTTATCTGCTTTTATACCAAATAAATTATTACTCTGTTTTGTAAG  616 
 
Query  407  TTTAGAATTTCCCCAACCAGATTCTAATATAGCTTGTCCAATTGTTATAGAGGGCAATAT  466 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  615  TTTAGAATTTCCCCAACCAGATTCTAATATAGCTTGTCCAATTGTTATAGAGGGCAATAT  556 
 
Query  467  TCCATAATCAATATATTCTCTTATAGCTGAGTCTTCTAACTTCTTTATAAATTTAATTTT  526 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  555  TCCATAATCAATATATTCTCTTATAGCTGAGTCTTCTAACTTCTTTATAAATTTAATTTT  496 
 
Query  527  TTCATCACTACTATCTAATTGTTTATTTCCAAGGTATGTGTATTCTAAATCTTTCATGTA  586 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  495  TTCATCACTACTATCTAATTGTTTATTTCCAAGGTATGTGTATTCTAAATCTTTCATGTA  436 
 
Query  587  TTTTCTTGCTCTACTTTTTTGAGAAGAGTCAAATTTCAATTCGCTTAATACTTTATTAAA  646 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  435  TTTTCTTGCTCTACTTTTTTGAGAAGAGTCAAATTTCAATTCGCTTAATACTTTATTAAA  376 
 
Query  647  CTTTTTTACCTTATACACCTTTTCGCCTTTATCATTTTTATCTTCTACTATAAACTTTTC  706 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  375  CTTTTTTACCTTATACACCTTTTCGCCTTTATCATTTTTATCTTCTACTATAAACTTTTC  316 
 
Query  707  CCCTATATCCAATGTGTCTTTCTTTTTTATATTACTTAAATCTTCATCATGTATTACCAT  766 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  315  CCCTATATCCAATGTGTCTTTCTTTTTTATATTACTTAAATCTTCATCATGTATTACCAT  256 
 
Query  767  GTCTATAGCAAGTAANGCCTTCCAACTTAATTGGACCTTTCCATCTCCTGCTTCATCAGC  826 
            ||||||||||||||| |||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  255  GTCTATAGCAAGTAAGGCCTTCCAACTTAATTGGACCTTTCCATCTCCTGCTTCATCAGC  196 
 
Query  827  CACATCCATATAGTATTCAATTTTAGTACTTTTTAAATCCCTTACTTTGTATAATTCCTC  886 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  195  CACATCCATATAGTATTCAATTTTAGTACTTTTTAAATCCCTTACTTTGTATAATTCCTC  136
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